Literature DB >> 6738696

H-2-linked low-molecular weight polypeptide antigens assemble into an unusual macromolecular complex.

J J Monaco, H O McDevitt.   

Abstract

The major histocompatibility complex (MHC) is a cluster of tightly linked genes whose products are of central importance in the functioning of the immune system. Class I and II MHC antigens are integral membrane proteins which regulate cell-surface interactions between T cells and their targets, while class III antigens are components of the complement system of serum proteins. All available evidence indicates that the structure and function of the MHC and its gene products are highly conserved among species (for review, see ref.5). We recently reported the existence in murine cells of a fourth class of MHC-linked polypeptides which are biochemically and genetically distinct from previously identified MHC gene products: BALB.B anti-BALB/c (anti-H-2d) antiserum immunoprecipitates a set of 16 cytoplasmic low-molecular weight polypeptides (LMP) from BALB/c spleen cells and from the WEHI-3 cell line. The production of these peptides is coordinately regulated (by immune interferon) with the production of the class I and II MHC antigens, suggesting that they too are functionally relevant to the immune system. We demonstrate here that these 16 polypeptides are associated with one another in vivo as a very large (580,000-molecular weight, Mr) noncovalent complex. The unusual nature of this complex has allowed the non-immunochemical identification of similar complexes from (serologically negative) H-2b murine cells and from a human cell line. Thus, LMP antigens display two properties in common with other MHC antigens: they are both polymorphic and genetically conserved across species.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738696     DOI: 10.1038/309797a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  Immuno-waste exposure and further management.

Authors:  Robbert M Spaapen; Jacques Neefjes
Journal:  Nat Immunol       Date:  2012-01-19       Impact factor: 25.606

Review 2.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Developmental failure of chimeric embryos expressing high levels of H-2Dd transplantation antigens.

Authors:  L Jaffe; E J Robertson; E K Bikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

4.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 5.  The ubiquitin-proteasome system.

Authors:  Dipankar Nandi; Pankaj Tahiliani; Anujith Kumar; Dilip Chandu
Journal:  J Biosci       Date:  2006-03       Impact factor: 1.826

6.  A cluster of transcribed sequences between the Pb and Ob genes of the murine major histocompatibility complex.

Authors:  S Cho; M Attaya; M G Brown; J J Monaco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

7.  Allelic variants of the human putative peptide transporter involved in antigen processing.

Authors:  M Colonna; M Bresnahan; S Bahram; J L Strominger; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 8.  Proteasomes: multicatalytic proteinase complexes.

Authors:  A J Rivett
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

9.  Novel HLA class II-associated structural patterns in coeliac disease and type I diabetes.

Authors:  N Fernandez; G A Hitman; H Festenstein; L Garde; M Labeta; J A Walker-Smith; J A Sachs
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Molecular basis of genetic polymorphism in major histocompatibility complex-linked proteasome gene (Lmp-2).

Authors:  P Zhou; H Cao; M Smart; C David
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.